Savara (SVRA) Shares Outstanding (Entity) (2014 - 2025)

Savara (SVRA) Shares Outstanding (Entity) (2014 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 254.16 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 200.18 Mn
10 Savara 1.39 Bn 1.39 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 216.43 Mn
Mar 31, 2025 216.15 Mn
Dec 31, 2024 172.42 Mn
Sep 30, 2024 170.84 Mn
Jun 30, 2024 182.58 Mn
Mar 31, 2024 182.55 Mn
Dec 31, 2023 138.14 Mn
Sep 30, 2023 135.34 Mn
Jun 30, 2023 152.80 Mn
Mar 31, 2023 152.78 Mn
Dec 31, 2022 152.77 Mn
Sep 30, 2022 152.77 Mn
Jun 30, 2022 152.77 Mn
Mar 31, 2022 152.77 Mn
Dec 31, 2021 114.04 Mn
Sep 30, 2021 152.59 Mn
Jun 30, 2021 152.46 Mn
Mar 31, 2021 76.99 Mn
Dec 31, 2020 54.15 Mn
Sep 30, 2020 54.14 Mn